Latest Alpha Tau Medical News & Updates
See the latest news and media coverage for Alpha Tau. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of alpha radiation therapy for cancer
alphatau.com- Headquarters
- Jerusalem , Israel
- Founded year
- 2016
- Company type
- Private company
- Number of employees
- 100–200
Last updated
Latest news about Alpha Tau Medical (Alpha Tau)
In short: Alpha Tau completed enrollment for its pivotal U.S. skin cancer trial and reported promising interim data for recurrent glioblastoma treatments.
Company announcements
-
Alpha Tau reports 100% local control in glioblastoma trial
The first three patients treated showed a 67% complete response rate, with a favorable safety profile.
-
Alpha Tau completes enrollment in pivotal U.S. trial
Enrollment of all 88 recurrent cSCC patients in the ReSTART pivotal study is complete. Company has initiated a modular PMA submission following FDA Breakthrough Device designation.
-
Alpha Tau achieves 100% local disease control in pancreatic cancer
The pooled analysis of two trials showed favorable safety, with only 27% of patients experiencing device-related adverse events.
-
Alpha Tau announces FDA approval to expand pancreatic cancer trial
The expansion allows ten additional patients receiving gemcitabine/nab-paclitaxel and increases total trial size to 40 patients.
Media coverage
-
Ladenburg Thalmann Maintains Buy on Alpha Tau Medical, Raises Price Target to...
Ladenburg Thalmann analyst Jeff Cohen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $12 to $14.
-
Alpha Tau and GE HealthCare mark breakthroughs in radiation therapy
Trial milestone reached: Alpha Tau completed enrolment of 88 patients in its US ReSTART trial for recurrent skin cancer, a key step toward possible FDA...
-
Alpha Tau Medical Shares Gain on Positive Results from Brain-Cancer Treatment Trial
Shares of Alpha Tau Medical climbed after the company disclosed what it called groundbreaking interim results from a trial of its treatment for certain brain...
-
DRTSW (Alpha Tau W) reports quarter with key metrics unavailable as Alpha Tau...
Stay informed with our comprehensive news tools designed for active investors who need timely market information. Alpha Tau W (DRTSW), the warrant associated with Alpha...
Track Alpha Tau and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.